UPDATE : Tuesday, September 17, 2019
상단여백
Eutilex pipelines are underrated: CEO
Eutilex CEO Kwon Byeong-se said he felt sorry for the recent fall of the co...
by Jeong Sae-im  |  2019-08-01 16:08
라인
‘Recurrent chronic lymphocytic leukemia needs various treatment options’
Chronic lymphocytic leukemia (CLL) progresses more slowly than acute blood ...
by Kim Yun-mi  |  2019-08-01 15:31
라인
Health ministry to reimburse Novartis’ Revolade treating severe aplastic anemia
Novartis Korea’s Revolade (ingredient: eltrombopag) will receive reimbursem...
by Lee Han-soo  |  2019-08-01 13:36
라인
‘NOAC treatment effective against liver disease-associated atrial fibrillation’
Researchers at Seoul National University Hospital have found that non-vitam...
by Lee Han-soo  |  2019-08-01 13:35
라인
New weight loss drug Qsymia wins local approval
The local drug regulator has approved a new obesity treatment, Qsymia Cap. ...
by Lee Hye-seon  |  2019-08-01 10:57
라인
‘Hanmi’s Carnitil improves cognitive function in patients’
Hanmi Pharmaceutical said that it has presented the phase 4 clinical trial ...
by Lee Han-soo  |  2019-07-31 17:05
라인
Hanall marks record sales in Q2
Hanall Biopharma said that it registered record-breaking sales and operatin...
by Lee Han-soo  |  2019-07-31 17:00
라인
[Column] Drug regulator needs adequate expertise to promote medical devices
In the healthcare sector, the medical device industry has the largest growt...
by Korea Biomedical Review  |  2019-07-31 16:59
라인
T&R Biofab gets Philippine nod for medical device
T&R Biofab said Wednesday that it has obtained sales approval from the Phil...
by Lee Han-soo  |  2019-07-31 15:44
라인
Lunit's AI-based software assisting breast cancer diagnosis wins regulatory nod
Lunit said that it has received approval for "Lunit INSIGHT for Mammography...
by Lee Han-soo  |  2019-07-31 14:31
라인
Novartis fails to expand heart failure drug Entresto’s indication
Novartis said its phase-3 Paragon-HF trial on heart failure treatment Entre...
by Kim Yun-mi  |  2019-07-31 14:26
라인
Journal of Stroke tops citation index among domestic journals
Journal of Stroke, a journal by the Korean Stroke Society, ranked No. 1 in ...
by Song Soo-youn  |  2019-07-31 11:38
라인
Hanmi marks ₩270.4 billion in Q2 sales
Hanmi Pharmaceutical said Tuesday that it recorded sales of 270.4 billion w...
by Lee Han-soo  |  2019-07-30 17:26
라인
Allergan recalls breast implants
Allergan said it has issued a worldwide recall of "Biocell" textured breast...
by Lee Han-soo  |  2019-07-30 16:23
라인
One in 45 Koreans prescribed with diet pills
One in 45 Koreans was prescribed with an appetite suppressant for obesity t...
by Lee Hye-seon  |  2019-07-30 15:44
라인
Kolmar Korea boosts beauty, health biz through acquisitions
Kolmar Korea Holdings, having units in cosmetics, pharmaceuticals, and heal...
by Park Gi-taek  |  2019-07-30 14:43
라인
Diabetic women with heart failure have higher risk of recurrence, death than men
A research team at Seoul National University Boramae Hospital has discovere...
by Lee Han-soo  |  2019-07-30 14:42
라인
Rare Fabry disease depicted in K-dramas
Recent SBS drama “Doctor John” and MBC’s “Partners for Justice Season 2” us...
by Lee Hye-seon  |  2019-07-30 12:40
라인
H+ Yangji Hospital makes accord with Mongolian hospital
H+ Yangji Hospital said that it has signed a medical agreement with Mongoli...
by Lee Han-soo  |  2019-07-30 12:38
라인
GC’s Chinese partner applies for Hunter syndrome drug’s sales approval
GC said that CANBridge Pharmaceuticals, its Chinese partner, has applied fo...
by Lee Han-soo  |  2019-07-30 10:49
여백
여백
여백
Back to Top